Skip to main content
🎂 — | ♂/♀ M/F | ⚖️ — kg | 📏 — cm | BMI — | 👟 —
⚡ 88%
🩺 Chronic Disease Meds

ꯅꯣꯡꯃꯩ ꯀꯥꯞꯄꯥ ꯌꯥꯕꯥ ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ ꯄꯤꯂꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯍꯦꯟꯅꯥ ꯈꯪꯖꯤꯅꯁꯤ꯫ (ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ) ꯑꯃꯁꯨꯡ ꯑꯦꯟ.

MBBS
Medically Reviewed by MBBS ✓ Medically Reviewed
📅 Updated: Jul 15, 2026 • ⏱ 7 min read • ꯑꯦꯗꯤꯇꯣꯔꯤꯌꯜ ꯄꯣꯂꯤꯁꯤ꯫
ꯅꯣꯡꯃꯩ ꯀꯥꯞꯄꯥ ꯌꯥꯕꯥ ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ ꯄꯤꯂꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯍꯦꯟꯅꯥ ꯈꯪꯖꯤꯅꯁꯤ꯫ (ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ) ꯑꯃꯁꯨꯡ ꯑꯦꯟ.
Table of Contents ▾

ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯅꯍꯥꯀꯄꯨ ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ ꯀꯧꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯥ ꯄꯤꯕꯤꯔꯕ꯭ꯔꯥ? ꯅꯠꯔꯒꯥ ꯑꯗꯣꯃꯒꯤ ꯏꯃꯨꯡꯒꯤ ꯀꯅꯥꯒꯨꯝꯕꯥ ꯑꯃꯗꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯄꯤꯕꯤꯔꯝꯂꯕꯔꯥ? ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯇꯃꯗꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯋꯥꯈꯂꯒꯤ ꯑꯅꯥꯕꯁꯤꯡꯗꯁꯨ ꯁꯤꯖꯤꯟꯅꯩ꯫ ꯑꯗꯨꯅꯥ ꯉꯁꯤꯗꯤ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯀꯔꯤꯅꯣ, ꯃꯁꯤꯅꯥ ꯀꯔꯤ ꯇꯧꯔꯤꯕꯒꯦ, ꯑꯃꯁꯨꯡ ꯃꯁꯤ ꯁꯤꯖꯤꯟꯅꯔꯀꯄꯥ ꯃꯇꯃꯗꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯌꯥꯝꯅꯥ ꯂꯥꯏꯅꯥ ꯑꯃꯁꯨꯡ ꯑꯀꯛꯅꯅꯥ ꯋꯥꯔꯤ ꯁꯥꯁꯤ꯫

⚡ Interactive Clinical Tool
⚖️

BMI Calculator

Know your body mass index (BMI) and weight classification

Open Interactive Calculator →

ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯇꯁꯦꯡꯅꯥ ꯀꯔꯤ ꯊꯣꯛꯂꯤꯕꯅꯣ?

ꯌꯥꯝꯅꯥ ꯂꯥꯏꯅꯥ ꯍꯥꯌꯔꯕꯗꯥ, ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ ꯑꯁꯤ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯅꯣꯡꯃꯩ ꯀꯥꯞꯄꯥ ꯑꯃꯁꯨꯡ ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯗ꯭ꯔꯒ ꯑꯃꯅꯤ꯫ ꯗ꯭ꯔꯒ ꯑꯁꯤꯅꯥ ꯇꯧꯔꯤꯕꯥ ꯑꯁꯤ ꯑꯩꯈꯣꯌꯒꯤ ꯕ꯭ꯔꯦꯅꯅꯥ ꯊꯥꯔꯀꯄꯥ ꯁꯤꯒꯅꯦꯂꯁꯤꯡ ꯑꯗꯨ ꯕ꯭ꯂꯣꯛ ꯇꯧꯕꯅꯤ꯫ ꯃꯁꯤ ꯅꯣꯡꯃꯩ ꯀꯥꯞꯄꯒꯤ ꯊꯣꯡ ꯂꯣꯅꯁꯤꯅꯕꯒꯥ ꯃꯥꯟꯅꯩ꯫

ꯃꯁꯤꯒꯤ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯋꯥꯈꯂꯒꯤ ꯑꯅꯥꯕꯥ ꯈꯔꯁꯨ ꯂꯥꯌꯦꯡꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯩ, ꯃꯔꯨꯑꯣꯏꯅꯥ ꯁ꯭ꯀꯤꯖꯣꯐ꯭ꯔꯦꯅꯤꯌꯥ . ꯃꯁꯤꯅꯥ ꯕ꯭ꯔꯦꯅꯗꯥ ꯗꯣꯄꯥꯃꯥꯏꯟ ꯀꯧꯕꯥ ꯀꯦꯃꯤꯀꯦꯜ ꯑꯃꯒꯤ ꯆꯥꯡ ꯑꯗꯨ ꯕꯦꯂꯦꯟꯁ ꯇꯧꯗꯨꯅꯥ ꯊꯕꯛ ꯇꯧꯏ꯫ ꯃꯁꯤꯒꯤ ꯗꯣꯄꯥꯃꯥꯏꯟ ꯑꯁꯤ ꯑꯩꯈꯣꯌꯒꯤ ꯋꯥꯈꯜ, ꯂꯃꯆꯠ-ꯁꯥꯖꯠ ꯑꯃꯁꯨꯡ ꯋꯥꯈꯜ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯕꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯂꯤꯕꯥ ꯄꯣꯠꯁꯛ ꯑꯃꯅꯤ꯫ ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯃꯁꯤ ꯕꯦꯂꯦꯟꯁ ꯑꯣꯏꯕꯥ ꯃꯇꯃꯗꯥ ꯑꯅꯥꯕꯥ ꯑꯗꯨ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯕꯗꯥ ꯍꯦꯟꯅꯥ ꯂꯥꯌꯕꯥ ꯑꯣꯏ꯫

ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯋꯥꯐꯃꯗꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯑꯇꯣꯞꯄꯥ ꯃꯦꯗꯤꯀꯦꯜ ꯀꯟꯗꯤꯁꯅꯁꯤꯡꯗꯁꯨ ꯄꯤꯕꯥ ꯌꯥꯏ꯫ ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯐꯕꯥ ꯊꯕꯛ ꯑꯗꯨꯗꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯍꯥꯌꯔꯀꯄꯥ ꯑꯗꯨ ꯇꯥꯗꯨꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯗꯨ ꯄꯤꯔꯀꯄꯒꯤ ꯃꯇꯨꯡ ꯏꯟꯅꯥ ꯁꯤꯖꯤꯟꯅꯕꯅꯤ꯫

ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯂꯧꯗ꯭ꯔꯤꯉꯩ ꯃꯃꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯄꯤꯗ꯭ꯔꯤꯉꯩ ꯃꯃꯥꯡꯗꯥ, ꯅꯍꯥꯛꯅꯥ ꯃꯍꯥꯛꯀꯤ ꯃꯦꯗꯤꯀꯦꯜ ꯀꯟꯗꯤꯁꯟ ꯑꯃꯍꯦꯛꯇꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯁꯣꯌꯗꯅꯥ ꯑꯃꯁꯨꯡ ꯄꯨꯀꯆꯦꯜ ꯁꯦꯡꯅꯥ ꯈꯪꯍꯅꯒꯗꯕꯅꯤ꯫ ꯍꯥꯌꯔꯤꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ ꯑꯁꯤ ꯂꯣꯠꯁꯤꯅꯕꯅꯥ ꯅꯍꯥꯀꯄꯨ ꯈꯨꯗꯣꯡꯊꯤꯕꯥ ꯅꯪꯍꯜꯂꯤ꯫

  • ꯕ꯭ꯔꯦꯟ ꯑꯃꯁꯨꯡ ꯅꯔꯚꯀꯤ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯃꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯗꯤꯃꯦꯅꯁꯤꯌꯥ, ꯕ꯭ꯔꯦꯟ ꯇꯤꯎꯃꯔ, ꯁꯤꯖ꯭ꯌꯨꯔ ꯅꯠꯠꯔꯒꯥ ꯄꯥꯔꯀꯤꯅꯁꯅꯁ ꯗꯤꯖꯤꯖ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯍꯥꯔꯇꯀꯤ ꯂꯥꯌꯅꯥ (hart disease): ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯥꯔꯇꯀꯤ ꯂꯥꯌꯅꯥ ꯂꯩꯔꯕꯗꯤ, ꯍꯥꯔꯇꯀꯤ ꯂꯥꯌꯅꯥꯅꯥ ꯅꯥꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯕ꯭ꯂꯗ ꯄ꯭ꯔꯦꯁꯔ ꯅꯦꯝꯕꯥ ꯑꯣꯏꯔꯕꯗꯤ꯫
  • ꯂꯤꯚꯔꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯂꯤꯚꯔꯒꯤ ꯂꯥꯌꯅꯥ ꯑꯃꯥ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯏꯒꯤ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯃꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯋꯥꯏꯠ ꯕ꯭ꯂꯗ ꯁꯦꯂꯁꯤꯡ, ꯄ꯭ꯂꯦꯇꯂꯦꯇꯁꯤꯡ ꯅꯠꯠꯔꯒꯥ ꯔꯦꯗ ꯕ꯭ꯂꯗ ꯁꯦꯂꯁꯤꯡ ꯍꯟꯊꯍꯅꯕꯥ ꯉꯝꯕꯥ ꯀꯟꯗꯤꯁꯟ ꯑꯃꯥ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯔꯦꯁ꯭ꯄꯤꯔꯦꯇꯔꯤ ꯁꯤꯁ꯭ꯇꯦꯃꯒꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯦꯖꯃꯥꯒꯨꯝꯕꯥ ꯂꯪꯁꯀꯤ ꯂꯥꯌꯅꯥꯁꯤꯡ ꯂꯩꯔꯕꯗꯤ꯫
  • ꯑꯇꯩ ꯍꯀꯆꯥꯡꯒꯤ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯃꯁꯤꯡ: ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖ, ꯒ꯭ꯂꯣꯀꯣꯃꯥ, ꯏꯟꯇꯦꯁ꯭ꯇꯥꯏꯅꯒꯤ ꯑꯁꯣꯛ-ꯑꯄꯟ, ꯂꯧꯅꯒꯅꯕꯥ ꯂꯥꯌꯅꯥ, ꯌꯨꯔꯤꯅꯔꯤꯕꯁꯤ ꯋꯥꯠꯄꯥ, ꯅꯠꯠꯔꯒꯥ ꯄ꯭ꯔꯣꯁ꯭ꯇꯦꯇꯀꯤ ꯂꯥꯌꯅꯥ꯫
  • ꯂꯅꯥꯏꯒꯤ ꯑꯣꯏꯕꯥ ꯂꯃꯆꯠ-ꯁꯥꯖꯠ ꯑꯃꯁꯨꯡ ꯑꯦꯂꯥꯔꯖꯤ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯊꯀꯄꯥ ꯌꯥꯕꯥ ꯑꯣꯏꯔꯕꯗꯤ, ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ ꯅꯠꯠꯔꯒꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ, ꯆꯤꯟꯖꯥꯛ ꯅꯠꯠꯔꯒꯥ ꯗꯥꯏꯑꯦꯇꯔꯤ ꯑꯃꯍꯦꯛꯇꯒꯤ ꯑꯦꯂꯥꯔꯖꯤ ꯂꯩꯒꯗꯕꯅꯤ꯫
  • ꯃꯤꯔꯣꯅꯕꯥ ꯑꯃꯁꯨꯡ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯀꯄꯥ: ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯤꯔꯣꯜꯂꯤꯕꯥ, ꯃꯤꯔꯣꯅꯕꯥ ꯍꯣꯠꯅꯔꯤꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯈꯣꯝꯂꯥꯡ ꯄꯤꯊꯛꯂꯤꯕꯥ ꯑꯣꯏꯔꯕꯗꯤ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯂꯤꯁ꯭ꯠ ꯑꯁꯤꯗꯥ ꯌꯥꯎꯔꯤꯕꯥ ꯋꯥꯐꯝ ꯑꯃꯠꯇꯥ ꯅꯍꯥꯛꯀꯤꯗꯃꯛꯇꯥ ꯑꯦꯞꯂꯥꯏ ꯇꯧꯔꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯈꯟꯅ-ꯅꯩꯅꯕꯗꯥ ꯂꯥꯡꯇꯛꯅꯒꯅꯨ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯀꯔꯝꯅꯥ ꯁꯤꯖꯤꯟꯅꯒꯗꯒꯦ?

ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯁꯤꯖꯤꯟꯅꯕꯒꯤ ꯃꯑꯣꯡ ꯑꯁꯤꯁꯨ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

  • ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯏꯁꯤꯡꯒꯤ ꯒ꯭ꯂꯥꯁ ꯑꯃꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯊꯀꯎ .
  • ꯄ꯭ꯔꯦꯁ꯭ꯛꯔꯥꯏꯕ ꯇꯧꯔꯕꯥ ꯗꯣꯖ ꯑꯗꯨ ꯈꯛꯇꯃꯛ ꯂꯧ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯅꯥ ꯄꯤꯕꯥ ꯃꯇꯃꯗꯥ꯫ ꯀꯩꯗꯧꯉꯩꯗꯥ ꯄ꯭ꯔꯦꯁ꯭ꯛꯔꯥꯏꯕ ꯇꯧꯕꯗꯒꯤ ꯍꯦꯟꯅꯥ ꯂꯧꯔꯣꯏꯗꯕꯅꯤ꯫
  • ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯃꯔꯨꯑꯣꯏꯕꯥ ꯋꯥꯐꯃꯗꯤ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯈꯉꯍꯧꯗꯅꯥ ꯊꯀꯄꯥ ꯂꯦꯄꯍꯅꯕꯥ ꯑꯁꯤ ꯑꯐꯕꯥ ꯋꯥꯈꯜꯂꯣꯟ ꯑꯃꯅꯤ꯫ ꯃꯁꯤ ꯇꯧꯕꯅꯥ ꯅꯥꯕꯥ, ꯈꯣꯝꯂꯥꯡ ꯑꯃꯁꯨꯡ ꯃꯤꯠ ꯎꯗꯕꯥ ꯊꯣꯀꯍꯜꯂꯀꯄꯥ ꯌꯥꯏ꯫ ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯗꯨ ꯂꯧꯕꯥ ꯂꯦꯄꯍꯅꯕꯥ ꯃꯊꯧ ꯇꯥꯔꯕꯗꯤ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯃꯇꯧ ꯀꯔꯝꯅꯥ ꯇꯧꯒꯗꯒꯦ ꯍꯥꯌꯕꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯤꯌꯨ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯑꯉꯥꯡꯁꯤꯡꯗꯥ ꯄꯤꯔꯕꯗꯤ: ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯑꯈꯟꯅꯕꯥ ꯀꯦꯁ ꯈꯔꯗꯗꯤ ꯆꯍꯤ 2ꯒꯤ ꯃꯊꯛꯇꯥ ꯂꯩꯕꯥ ꯑꯉꯥꯡꯁꯤꯡꯗꯥ ꯄꯤꯕꯥ ꯌꯥꯏ꯫ ꯑꯗꯨꯕꯨ ꯃꯁꯤ ꯄꯦꯗꯤꯑꯦꯠꯔꯤꯛ ꯑꯃꯒꯤ ꯌꯦꯡꯁꯤꯅꯕꯒꯤ ꯃꯈꯥꯗꯥ ꯈꯛꯇꯃꯛ ꯇꯧꯒꯗꯕꯅꯤ꯫ ꯃꯁꯤꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯑꯈꯟꯅꯕꯥ ꯃꯤꯠꯌꯦꯡ ꯆꯪꯒꯗꯕꯅꯤ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯣꯚꯔꯗꯣꯖ ꯇꯧꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯗꯣꯖ ꯑꯃꯥ ꯃꯥꯡꯈꯤꯕꯥ ꯇꯥꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯗꯒꯦ?

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯊꯀꯈ꯭ꯔꯦ ꯍꯥꯌꯅꯥ ꯈꯜꯂꯕꯗꯤ, ꯊꯦꯡꯊꯕꯥ ꯇꯧꯔꯣꯏꯗꯕꯅꯤ꯫ ꯈꯨꯗꯛꯇꯥ ꯀꯣꯂꯝꯕꯣ ꯅꯦꯁ꯭ꯅꯦꯜ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯦꯁ꯭ꯅꯦꯜ ꯄꯣꯏꯖꯅꯁ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯁꯦꯟꯇꯔꯗꯥ ꯐꯣꯟ ꯇꯧꯕꯤꯌꯨ . ꯅꯠꯠꯔꯒꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯅꯀꯄꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯒꯤ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯇ꯭ꯔꯤꯇꯃꯦꯟꯇ ꯌꯨꯅꯤꯠ (ETU)ꯗꯥ ꯆꯠꯂꯨ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯗꯣꯖ ꯑꯃꯥ ꯂꯧꯕꯥ ꯀꯥꯎꯔꯕꯗꯤ, ꯅꯍꯥꯛꯅꯥ ꯅꯤꯡꯁꯤꯡꯂꯀꯄꯥ ꯃꯇꯃꯗꯥ ꯌꯥꯝꯅꯥ ꯊꯨꯅꯥ ꯂꯧ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯀꯤ ꯃꯊꯪꯒꯤ ꯗꯣꯖꯒꯤ ꯃꯇꯝ ꯌꯧꯔꯛꯂꯕꯗꯤ, ꯃꯥꯡꯈꯤꯕꯥ ꯗꯣꯖ ꯑꯗꯨ ꯊꯥꯗꯣꯀꯎ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯀꯤ ꯃꯊꯪꯒꯤ ꯗꯣꯖ ꯑꯗꯨ ꯁꯦꯗ꯭ꯌꯨꯜ ꯇꯧꯔꯕꯥ ꯃꯇꯝ ꯑꯗꯨꯗꯥ ꯂꯧ꯫ ꯃꯔꯝ ꯑꯃꯠꯇꯗꯥ ꯗꯣꯖ ꯑꯅꯤ ꯂꯧꯔꯣꯏꯗꯕꯅꯤ꯫

ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯥ ꯃꯔꯤ ꯂꯩꯅꯕꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯀꯁꯤꯡ (Medication Interactions)

ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ ꯑꯁꯤ ꯍꯤꯗꯥꯛ ꯈꯔꯒꯥ ꯃꯔꯤ ꯂꯩꯅꯕꯥ ꯍꯤꯗꯥꯛ ꯑꯃꯅꯤ, ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯛ ꯄꯨꯝꯅꯃꯛꯀꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯥ ꯍꯥꯌꯕꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫

ꯍꯤꯗꯥꯛ ꯃꯈꯜ꯫
ꯍꯤꯗꯥꯛ ꯑꯁꯤꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ ꯂꯧꯔꯣꯏꯗꯕꯅꯤ꯫
ꯁꯤꯁꯥꯞꯔꯥꯏꯗ, ꯗꯣꯐꯦꯇꯤꯂꯥꯏꯗ, ꯗ꯭ꯔꯣꯅꯦꯗꯥꯔꯣꯟ, ꯃꯦꯇꯣꯛꯂꯣꯞꯔꯥꯃꯥꯏꯗ, ꯄꯤꯃꯣꯖꯥꯏꯗ, ꯁꯥꯀꯤꯅꯥꯚꯤꯔ, ꯊꯤꯑꯣꯔꯤꯗꯥꯖꯤꯟ꯫
ꯍꯤꯗꯥꯀꯁꯤꯡ ꯑꯁꯤꯒꯥ ꯂꯣꯌꯅꯅꯥ ꯄ꯭ꯔꯣꯕ꯭ꯂꯦꯃꯁꯤꯡꯁꯨ ꯊꯣꯀꯄꯥ ꯌꯥꯏ (ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ)꯫
  • ꯌꯨ
  • ꯑꯦꯂꯥꯔꯖꯤ, ꯀꯣꯛ ꯆꯤꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯀꯣꯛ ꯆꯤꯀꯄꯒꯤ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ (Antihistamines)
  • ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ ꯅꯠꯠꯔꯒꯥ ꯇꯨꯝꯕꯥ ꯌꯥꯗꯕꯒꯤ ꯍꯤꯗꯥꯛ꯫
  • ꯗꯤꯞꯔꯦꯁꯅꯒꯤ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ (ꯈꯨꯗꯝ ꯑꯣꯏꯅꯥ, ꯑꯦꯃꯤꯠꯔꯤꯄꯇꯤꯂꯤꯟ, ꯐ꯭ꯂꯨꯑꯣꯛꯁꯦꯇꯤꯟ)
  • ꯕ꯭ꯂꯗ ꯄ꯭ꯔꯦꯁꯔꯒꯤ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡ꯫
  • ꯄꯥꯔꯀꯤꯅꯁꯅꯁ ꯗꯤꯖꯤꯖꯒꯤꯗꯃꯛ ꯂꯦꯚꯣꯗꯣꯄꯥꯒꯨꯝꯕꯥ ꯍꯤꯗꯥꯀꯁꯤꯡ꯫
  • ꯋꯥꯔꯐꯦꯔꯤꯅꯒꯨꯝꯕꯥ ꯕ꯭ꯂꯗ ꯊꯤꯅꯔꯁꯤꯡ꯫
  • ꯑꯦꯟꯇꯤꯏꯄꯤꯂꯦꯄꯇꯤꯛ ꯗ꯭ꯔꯒꯁꯤꯡ (ꯈꯨꯗꯝ ꯑꯣꯏꯅꯥ, ꯐꯦꯅꯣꯕꯥꯔꯕꯤꯇꯥꯜ, ꯐꯦꯅꯤꯇꯣꯏꯟ)
  • ꯁꯔꯖꯔꯤꯒꯤ ꯃꯇꯃꯗꯥ ꯑꯦꯅꯥꯁ꯭ꯇꯦꯁꯤꯌꯥ ꯑꯃꯁꯨꯡ ꯃꯁꯜ ꯔꯤꯂꯦꯛꯁꯟ ꯇꯧꯕꯗꯥ ꯁꯤꯖꯤꯟꯅꯕꯥ ꯍꯤꯗꯥꯀꯁꯤꯡ꯫
  • ꯄꯦꯏꯅꯀꯤꯂꯔꯁꯤꯡ (ꯃꯔꯨꯑꯣꯏꯅꯥ ꯑꯣꯄꯤꯑꯣꯏꯗꯁꯤꯡ)

ꯃꯁꯤꯒꯤ ꯂꯤꯁ꯭ꯠ ꯑꯁꯤ ꯃꯄꯨꯡ ꯐꯥꯗ꯭ꯔꯤ꯫ ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯚꯤꯇꯥꯃꯤꯟ ꯅꯠꯠꯔꯒꯥ ꯍꯔꯕꯦꯜ ꯄ꯭ꯔꯗꯛꯇ ꯑꯃꯍꯦꯛꯇꯒꯤ ꯃꯇꯥꯡꯗꯁꯨ ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯈꯪꯍꯅꯕꯤꯌꯨ꯫

ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯂꯧꯕꯥ ꯃꯇꯃꯗꯥ ꯋꯥꯈꯂꯗꯥ ꯊꯃꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

  • ꯗ꯭ꯔꯥꯏꯚꯤꯡ ꯑꯃꯁꯨꯡ ꯑꯣꯄꯔꯦꯁꯟ ꯃꯦꯁꯤꯅꯔꯤ: ꯍꯤꯗꯥꯛ ꯑꯁꯤꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯄꯨꯛꯅꯤꯡ ꯆꯪꯕꯥ ꯑꯃꯁꯨꯡ ꯋꯥꯔꯦꯞ ꯂꯧꯕꯒꯤ ꯈꯣꯡꯖꯦꯂꯗꯥ ꯑꯀꯥꯌꯕꯥ ꯄꯤꯕꯥ ꯌꯥꯏ꯫ ꯃꯔꯝ ꯑꯗꯨꯅꯥ , ꯍꯤꯗꯥꯛ ꯑꯁꯤꯅꯥ ꯅꯍꯥꯀꯄꯨ ꯀꯔꯝꯅꯥ ꯁꯣꯀꯍꯅꯕꯒꯦ ꯍꯥꯌꯕꯗꯨ ꯈꯪꯗ꯭ꯔꯤꯐꯥꯎꯕꯥ ꯗ꯭ꯔꯥꯏꯚꯤꯡ ꯅꯠꯠꯔꯒꯥ ꯍꯦꯚꯤ ꯃꯦꯁꯤꯅꯔꯤ ꯑꯣꯄꯔꯦꯠ ꯇꯧꯔꯣꯏꯗꯕꯅꯤ꯫
  • ꯃꯤꯠ ꯎꯏꯁꯤꯅꯕꯥ: ꯃꯤꯠ ꯎꯗꯕꯒꯤ ꯔꯤꯁ꯭ꯛ ꯍꯟꯊꯍꯟꯅꯕꯒꯤꯗꯃꯛ, ꯐꯃꯐꯝ ꯑꯃꯗꯒꯤ ꯅꯠꯠꯔꯒꯥ ꯐꯃꯨꯡꯗꯒꯤ ꯊꯣꯔꯀꯄꯥ ꯃꯇꯃꯗꯥ ꯇꯞꯅꯥ ꯇꯞꯅꯥ ꯇꯨꯝꯃꯨ꯫ ꯌꯨ ꯊꯀꯄꯅꯥ ꯀꯟꯗꯤꯁꯟ ꯑꯁꯤ ꯍꯦꯟꯅꯥ ꯐꯠꯆꯤꯜꯂꯛꯇꯕꯥ ꯌꯥꯏ꯫
  • ꯍꯀꯆꯥꯡꯒꯤ ꯇꯦꯝꯄꯦꯔꯦꯆꯔ: ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯃꯔꯨꯑꯣꯏ꯫ ꯍꯤꯗꯥꯛ ꯑꯁꯤꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯍꯀꯆꯥꯡꯗꯥ ꯍꯤꯠ ꯑꯃꯁꯨꯡ ꯀꯣꯜꯗ ꯔꯤꯒꯨꯂꯦꯠ ꯇꯧꯕꯗꯥ ꯑꯋꯥꯕꯥ ꯄꯤꯕꯥ ꯌꯥꯏ꯫
  • ꯅꯣꯡꯖꯨ-ꯅꯨꯡꯁꯥꯗꯥ: ꯌꯥꯔꯤꯕꯃꯈꯩ ꯌꯨꯃꯒꯤ ꯃꯅꯨꯡꯗꯥ ꯂꯩꯌꯨ꯫ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯃꯄꯥꯟꯗꯥ ꯆꯠꯂꯕꯗꯤ, ꯅꯨꯡꯉꯥꯏꯅꯥ ꯄꯣꯠ ꯌꯣꯜꯂꯨ꯫
  • ꯑꯁꯥꯕꯥ ꯋꯦꯗꯔꯗꯥ: ꯅꯨꯃꯤꯠꯀꯤ ꯃꯉꯥꯂꯅꯥ ꯊꯜꯂꯕꯥ ꯃꯇꯃꯗꯥ ꯂꯤꯃꯤꯠ ꯂꯩꯍꯅꯒꯗꯕꯅꯤ꯫ ꯑꯦꯛꯁꯔꯁꯥꯏꯖ ꯌꯥꯝꯅꯥ ꯇꯧꯔꯣꯏꯗꯕꯅꯤ꯫ ꯂꯨꯖꯔꯕꯥ, ꯂꯥꯏꯠ ꯑꯣꯏꯕꯥ ꯄꯣꯠꯁꯀꯁꯤꯡ ꯁꯤꯖꯤꯟꯅꯧ꯫ ꯏꯁꯤꯡ ꯃꯔꯥꯡ ꯀꯥꯌꯅꯥ ꯊꯀꯎ꯫
  • ꯕ꯭ꯂꯗ ꯁꯨꯒꯔ: ꯍꯤꯗꯥꯛ ꯑꯁꯤꯅꯥ ꯕ꯭ꯂꯗ ꯁꯨꯒꯔꯒꯤ ꯆꯥꯡ ꯍꯦꯅꯒꯠꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯗꯥꯏꯑꯦꯕꯦꯇꯤꯖꯅꯥ ꯅꯥꯕꯥ ꯃꯤꯑꯣꯏꯁꯤꯡꯅꯥ ꯃꯁꯤꯒꯥ ꯃꯔꯤ ꯂꯩꯅꯅꯥ ꯃꯔꯨꯑꯣꯏꯅꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯅꯤ꯫
  • ꯅꯨꯃꯤꯠꯀꯤ ꯁꯦꯟꯁꯤꯇꯤꯕꯤꯇꯤ (sun sensitivity): ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯆꯥꯔꯤꯉꯩꯗꯥ ꯅꯍꯥꯛꯀꯤ ꯈꯣꯡꯗꯥ ꯅꯨꯃꯤꯠꯇꯥ ꯌꯥꯝꯅꯥ ꯁꯦꯟꯁꯤꯇꯤꯚ ꯑꯣꯏꯕꯥ ꯌꯥꯏ꯫ ꯃꯔꯝ ꯑꯗꯨꯅꯥ ꯅꯍꯥꯛꯀꯤ ꯏꯁꯥꯕꯨ ꯅꯨꯃꯤꯠꯇꯒꯤ ꯉꯥꯀꯊꯣꯀꯄꯤꯌꯨ꯫ ꯁꯥꯇꯤꯟ ꯑꯃꯥ ꯁꯤꯖꯤꯟꯅꯧ ꯑꯃꯁꯨꯡ ꯅꯨꯃꯤꯠꯀꯤ ꯃꯉꯥꯜ ꯁꯤꯖꯤꯟꯅꯧ꯫
  • ꯃꯤꯠ ꯁꯣꯀꯄꯥ: ꯅꯍꯥꯛꯅꯥ ꯃꯤꯠ ꯁꯣꯀꯄꯥ ꯊꯦꯡꯅꯔꯀꯄꯥ ꯌꯥꯏ꯫ ꯆꯤꯅꯤ ꯌꯥꯎꯗꯕꯥ ꯈꯣꯡꯎꯞ ꯆꯦꯅꯕꯥ, ꯆꯤꯅꯤ ꯌꯥꯎꯗꯕꯥ ꯀꯦꯟꯗꯤꯗꯦꯇꯁꯤꯡ ꯆꯨꯃꯊꯣꯀꯄꯥ ꯑꯃꯁꯨꯡ ꯏꯁꯤꯡ ꯃꯔꯥꯡ ꯀꯥꯌꯅꯥ ꯊꯀꯄꯅꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯏ꯫

ꯑꯣꯏꯊꯣꯀꯄꯥ ꯌꯥꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ ꯑꯗꯨ ꯀꯔꯤꯅꯣ?

ꯍꯤꯗꯥꯛ ꯑꯃꯍꯦꯛꯇꯒꯨꯝꯅꯥ ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ ꯑꯁꯤꯅꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯊꯣꯀꯍꯅꯕꯥ ꯌꯥꯏ꯫ ꯈꯔꯗꯤ ꯌꯥꯝꯅꯥ ꯂꯨꯕꯥ ꯑꯣꯏ, ꯑꯗꯨꯒꯥ ꯑꯇꯩ ꯈꯔꯗꯤ ꯀꯃꯟ ꯑꯣꯏ꯫

ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯑꯃꯁꯨꯡ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ꯫
ꯈꯨꯗꯛꯇꯥ ꯃꯦꯗꯤꯀꯦꯜ ꯑꯦꯇꯦꯟꯁꯟ ꯃꯊꯧ ꯇꯥꯕꯥ ꯁꯥꯊꯤꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ꯫
  • ꯑꯦꯂꯥꯔꯖꯤꯒꯤ ꯔꯤꯑꯦꯛꯁꯅꯁꯤꯡ: ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯈꯣꯡ-ꯈꯨꯠ ꯁꯣꯛ-ꯄꯅꯕꯥ, ꯃꯥꯌ, ꯅꯥꯀꯣꯡ, ꯈꯣꯡ ꯅꯠꯠꯔꯒꯥ ꯀꯣꯛ ꯆꯤꯀꯄꯥ꯫
  • ꯅ꯭ꯌꯨꯔꯣꯂꯦꯞꯇꯤꯛ ꯃꯦꯂꯤꯒꯅꯦꯟꯇ ꯁꯤꯟꯗ꯭ꯔꯣꯝ (NMS): ꯌꯥꯝꯅꯥ ꯋꯥꯡꯕꯥ ꯂꯥꯏꯍꯧ, ꯃꯁꯜ ꯁꯣꯟꯊꯕꯥ, ꯌꯥꯝꯅꯥ ꯋꯥꯅꯥ ꯏꯪꯊꯕꯥ, ꯌꯥꯝꯅꯥ ꯊꯨꯅꯥ ꯅꯠꯠꯔꯒꯥ ꯆꯥꯡ ꯅꯥꯏꯅꯥ ꯊꯝꯃꯣꯌ ꯁꯣꯀꯄꯥ, ꯑꯃꯁꯨꯡ ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ꯫ ꯃꯁꯤ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯑꯃꯅꯤ꯫
  • ꯄ꯭ꯔꯣꯂꯥꯛꯇꯤꯅꯒꯤ ꯆꯥꯡ ꯋꯥꯡꯈꯠꯄꯥ: ꯎꯅꯁꯥꯗꯒꯤ ꯁꯉ꯭ꯒꯣꯃꯒꯤ ꯐ꯭ꯂꯨꯏꯗ ꯑꯃꯥ ꯊꯣꯀꯄꯥ, ꯅꯨꯄꯤꯁꯤꯡꯗꯥ ꯊꯥꯒꯤ ꯈꯣꯡꯀꯥꯞ ꯊꯣꯀꯄꯥ, ꯁꯦꯛꯁꯀꯤ ꯑꯄꯥꯝꯕꯗꯥ ꯑꯍꯣꯡꯕꯥ ꯂꯥꯀꯄꯥ꯫
  • ꯏꯅꯐꯦꯛꯁꯅꯒꯤ ꯂꯥꯏꯑꯣꯡꯁꯤꯡ: ꯂꯥꯏꯍꯧ, ꯆꯤꯀꯄꯥ, ꯀꯣꯛ ꯆꯤꯀꯄꯥ, ꯀꯣꯛ ꯆꯤꯀꯄꯥ꯫
  • ꯕ꯭ꯂꯗ ꯄ꯭ꯔꯦꯁꯔ ꯅꯦꯝꯕꯥ: ꯃꯤꯠ ꯎꯗꯕꯥ, ꯃꯁꯥ ꯃꯊꯟꯇꯥ ꯋꯥꯈꯜ ꯇꯥꯗꯕꯥ, ꯃꯤꯠ ꯎꯗꯕꯥ꯫
  • ꯑꯦꯛꯁꯠꯔꯥꯄꯤꯔꯥꯃꯤꯗ ꯁꯤꯝꯄꯇꯃꯁꯤꯡ (EPS): ꯍꯀꯆꯥꯡꯒꯤ ꯁꯔꯨꯀꯁꯤꯡ (ꯃꯔꯨꯑꯣꯏꯅꯥ ꯃꯥꯌ ꯑꯃꯁꯨꯡ ꯃꯤꯠ) ꯀꯟꯠꯔꯣꯜ ꯇꯧꯗꯕꯥ, ꯃꯁꯜ ꯁꯣꯟꯊꯕꯥ, ꯈꯣꯡ ꯍꯥꯝꯕꯥ, ꯈꯣꯡꯅꯥ ꯆꯠꯄꯥ ꯃꯇꯃꯗꯥ ꯕꯦꯂꯦꯟꯁ ꯃꯥꯡꯈꯤꯕꯥ, ꯋꯥꯈꯜ ꯅꯨꯡꯉꯥꯏꯇꯕꯥ꯫
ꯃꯍꯧꯁꯥꯅꯥ ꯌꯥꯝꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯑꯣꯏꯗꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇꯁꯤꯡ, ꯑꯗꯨꯕꯨ ꯀꯔꯤꯒꯨꯝꯕꯥ ꯃꯈꯣꯌ ꯑꯁꯤ ꯂꯦꯡꯗꯅꯥ ꯂꯩꯔꯕꯗꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯔꯤꯄꯣꯔꯠ ꯇꯧꯒꯗꯕꯅꯤ꯫
  • ꯈꯣꯉ ꯍꯥꯝꯕ ꯌꯥꯗꯕ
  • ꯃꯃꯤꯠ ꯇꯥꯡꯕꯥ꯫
  • ꯇꯨꯝꯕꯥ ꯌꯥꯗꯕꯥ꯫
  • ꯃꯤꯠ ꯁꯣꯀꯄꯥ꯫

ꯇꯦꯛ-ꯍꯣꯝ ꯃꯦꯁꯦꯖ ꯇꯧꯕꯥ꯫

  • ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ ꯑꯁꯤ ꯗꯣꯛꯇꯔ ꯑꯃꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯈꯛꯇꯗꯥ ꯁꯤꯖꯤꯟꯅꯒꯗꯕꯅꯤ꯫ ꯄꯤꯔꯤꯕꯥ ꯗꯣꯖ ꯑꯗꯨꯗꯒꯤ ꯍꯦꯟꯅꯥ ꯂꯧꯔꯣꯏꯗꯕꯅꯤ꯫
  • ꯍꯤꯗꯥꯛ ꯑꯗꯨ ꯂꯧꯗ꯭ꯔꯤꯉꯩ ꯃꯃꯥꯡꯗꯥ, ꯅꯍꯥꯛꯀꯤ ꯗꯣꯛꯇꯔꯗꯥ ꯅꯍꯥꯛꯅꯥ ꯊꯦꯡꯅꯔꯤꯕꯥ ꯑꯇꯩ ꯑꯅꯥꯕꯥ ꯑꯃꯍꯦꯛꯇꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯅꯥ ꯂꯧꯔꯤꯕꯥ ꯑꯇꯩ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯀꯁꯤꯡꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯈꯪꯍꯜꯂꯨ꯫
  • ꯗꯣꯛꯇꯔꯒꯥ ꯇꯥꯟꯅꯗꯅꯥ ꯍꯤꯗꯥꯛ-ꯂꯥꯡꯊꯛ ꯑꯗꯨ ꯈꯪꯍꯧꯗꯅꯥ ꯂꯧꯕꯥ ꯂꯦꯄꯀꯅꯨ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯁꯥꯊꯤꯕꯥ ꯁꯥꯏꯗ ꯏꯐꯦꯛꯇ ꯑꯃꯍꯦꯛꯇ, ꯍꯥꯌꯕꯗꯤ ꯂꯥꯏꯍꯧ ꯍꯧꯕꯥ, ꯃꯁꯜ ꯁꯣꯟꯊꯕꯥ, ꯅꯠꯠꯔꯒꯥ ꯀꯟꯠꯔꯣꯜ ꯇꯧꯗꯕꯥ ꯈꯣꯡꯖꯦꯜ ꯌꯥꯡꯅꯥ ꯆꯠꯄꯥ , ꯈꯨꯗꯛꯇꯥ ꯃꯦꯗꯤꯀꯦꯂꯒꯤ ꯄꯥꯎꯇꯥꯛ ꯂꯧꯕꯤꯌꯨ꯫
  • ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯆꯥꯔꯤꯉꯩꯗꯥ ꯌꯨ ꯃꯄꯨꯡꯐꯥꯅꯥ ꯊꯀꯄꯤꯒꯅꯨ꯫ ꯗ꯭ꯔꯥꯏꯚꯤꯡ ꯇꯧꯕꯥ ꯃꯇꯃꯗꯥ ꯌꯥꯝꯅꯥ ꯆꯦꯀꯁꯤꯅꯒꯗꯕꯅꯤ꯫
  • ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯣꯚꯔꯗꯣꯖꯒꯤ ꯆꯤꯡꯅꯕꯥ ꯂꯩꯔꯕꯗꯤ, ꯈꯨꯗꯛꯇꯥ ꯅꯦꯁꯅꯦꯜ ꯄꯣꯏꯖꯅꯁ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯁꯦꯟꯇꯔꯗꯥ ꯀꯣꯜ ꯇꯧꯕꯤꯌꯨ ꯅꯠꯠꯔꯒꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯅꯀꯄꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯜ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯗꯤꯄꯥꯔꯇꯃꯦꯟꯇ (ETU)ꯗꯥ ꯆꯠꯄꯤꯌꯨ꯫
❓ FAQ

FAQ

Evidence-based clinical answers to common patient questions

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯑꯣꯚꯔꯗꯣꯖ ꯇꯧꯔꯕꯗꯤ ꯅꯠꯠꯔꯒꯥ ꯗꯣꯖ ꯑꯃꯥ ꯃꯥꯡꯈꯤꯕꯥ ꯇꯥꯔꯕꯗꯤ ꯀꯔꯤ ꯇꯧꯒꯗꯒꯦ?

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯍꯤꯗꯥꯛ ꯑꯁꯤ ꯌꯥꯝꯅꯥ ꯊꯀꯈ꯭ꯔꯦ ꯍꯥꯌꯅꯥ ꯈꯜꯂꯕꯗꯤ, ꯊꯦꯡꯊꯕꯥ ꯇꯧꯔꯣꯏꯗꯕꯅꯤ꯫ ꯈꯨꯗꯛꯇꯥ ꯀꯣꯂꯝꯕꯣ ꯅꯦꯁ꯭ꯅꯦꯜ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯗꯥ ꯂꯩꯕꯥ ꯅꯦꯁ꯭ꯅꯦꯜ ꯄꯣꯏꯖꯅꯁ ꯏꯅꯐꯣꯔꯃꯦꯁꯟ ꯁꯦꯟꯇꯔꯗꯥ ꯐꯣꯟ ꯇꯧꯕꯤꯌꯨ . ꯅꯠꯠꯔꯒꯥ ꯈ꯭ꯕꯥꯏꯗꯒꯤ ꯅꯀꯄꯥ ꯍꯣꯁ꯭ꯄꯤꯇꯥꯂꯒꯤ ꯏꯃꯔꯖꯦꯟꯁꯤ ꯇ꯭ꯔꯤꯇꯃꯦꯟꯇ ꯌꯨꯅꯤꯠ (ETU)ꯗꯥ ꯆꯠꯂꯨ꯫

ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯅꯥ ꯗꯣꯖ ꯑꯃꯥ ꯂꯧꯕꯥ ꯀꯥꯎꯔꯕꯗꯤ, ꯅꯍꯥꯛꯅꯥ ꯅꯤꯡꯁꯤꯡꯂꯀꯄꯥ ꯃꯇꯃꯗꯥ ꯌꯥꯝꯅꯥ ꯊꯨꯅꯥ ꯂꯧ꯫ ꯑꯗꯨꯝ ꯑꯣꯏꯅꯃꯛ, ꯀꯔꯤꯒꯨꯝꯕꯥ ꯅꯍꯥꯛꯀꯤ ꯃꯊꯪꯒꯤ ꯗꯣꯖꯒꯤ ꯃꯇꯝ ꯌꯧꯔꯛꯂꯕꯗꯤ, ꯃꯥꯡꯈꯤꯕꯥ ꯗꯣꯖ ꯑꯗꯨ ꯊꯥꯗꯣꯀꯎ ꯑꯃꯁꯨꯡ ꯅꯍꯥꯛꯀꯤ ꯃꯊꯪꯒꯤ ꯗꯣꯖ ꯑꯗꯨ ꯁꯦꯗ꯭ꯌꯨꯜ ꯇꯧꯔꯕꯥ ꯃꯇꯝ ꯑꯗꯨꯗꯥ ꯂꯧ꯫ ꯃꯔꯝ ꯑꯃꯠꯇꯗꯥ ꯗꯣꯖ ꯑꯅꯤ ꯂꯧꯔꯣꯏꯗꯕꯅꯤ꯫

🔍 Search Keywords: prochlorperazine tablets • prochlorperazine tablets symptoms • prochlorperazine tablets causes and treatment • prochlorperazine tablets sri lanka • ꯅꯣꯡꯃꯩ ꯀꯥꯞꯄꯥ ꯌꯥꯕꯥ ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ ꯄꯤꯂꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯍꯦꯟꯅꯥ ꯈꯪꯖꯤꯅꯁꯤ꯫ (ꯄ꯭ꯔꯣꯛꯂꯣꯔꯄꯦꯔꯥꯖꯤꯟ) ꯑꯃꯁꯨꯡ ꯑꯦꯟ.

🩺 Articles For You

ꯄꯦꯅꯛꯔꯦꯂꯤꯄꯦꯖ ꯇꯦꯕꯂꯁꯤꯡꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯈꯪꯖꯤꯅꯁꯤ: ꯅꯍꯥꯛꯀꯤ ꯍꯀꯆꯥꯡꯗꯥ ꯃꯇꯦꯡ ꯄꯥꯡꯕꯥ꯫

ꯑꯉꯥꯡ ꯑꯗꯨꯕꯨ RSV ꯏꯅꯐꯦꯛꯁꯅꯁꯤꯡꯗꯒꯤ ꯉꯥꯀꯊꯣꯛꯅꯕꯥ ꯄꯤꯕꯥ ꯑꯈꯟꯅꯕꯥ ꯚꯦꯛꯁꯤꯟ (Respiratory Syncytial Virus Immune Globulin, RSV-IGIV)

HIV ꯂꯥꯏꯌꯦꯡꯕꯒꯤ ꯍꯤꯗꯥꯛ (Bictegravir; Emtricitabine; Tenofovir Alafenamide) ꯑꯁꯤꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯪꯖꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ

ꯖꯦꯟꯇꯥꯃꯤꯁꯤꯟ ꯏꯅꯖꯦꯀꯁꯅꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯪꯖꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ꯫

ꯗꯤꯋꯥꯔꯃꯤꯡ ꯃꯦꯗꯤꯁꯤꯟ (ꯑꯦꯂꯕꯦꯟꯗꯥꯖꯣꯜ)ꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯪꯖꯤꯅꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ

ꯀꯦꯟꯁꯔ ꯂꯥꯌꯦꯡꯕꯒꯤ ꯃꯇꯥꯡꯗꯥ ꯅꯍꯥꯛꯅꯥ ꯈꯉꯒꯗꯕꯥ ꯋꯥꯐꯃꯁꯤꯡ ꯑꯦꯅꯀꯣꯔꯥꯐꯦꯅꯤꯕ (ꯕ꯭ꯔꯥꯐꯇꯣꯚꯤ)

💬 Patient Questions & Comments (0)

Have a question or experience to share? Post a comment or reply to other readers below.

🛡️ Plain Text Only • No Links
👤

No comments yet. Be the first to share your question or experience below.

⚠️ Important: Medical articles and information on Nirogi Lanka are strictly for educational and awareness purposes and do not substitute professional medical advice, diagnosis, or treatment. Always consult a qualified physician for any medical concerns.